Citolab
- Company typePrivate
- Founded1989
- HeadquartersCuritiba, Brazil
- Headcount11–50
- GTM typeB2B
- OfferingServices
Citolab firmographics
Firmographics- Name
- Citolab
- Legal name
- Citolab Laboratório de Citologia Clínica e Histopatologia Ltda
- Website
- https://citolab.com.br
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Citolab industry classification
Industry- Product category
- Clinical Pathology Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
- akta.pro secondary industry
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Citolab is headquartered
LocationHeadquarters
- HQ city
- Curitiba
- HQ country
- Brazil
- HQ region
- Latin America
Offices3 records
Markets served
Citolab business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Clinical pathology services: Laboratory diagnostic services including cytology, histopathology, immunohistochemistry, and molecular testing for medical clinics, hospitals, and healthcare providers. Services are billed through health insurance plans (convênios) or direct patient payment.
- Specialized diagnostic testing: Advanced genetic testing services including NIPT, hereditary cancer panels, nutrigenetic tests (NutriGen), sports genetics (GymGen, FitGen), dermatogenetic testing (AgeGen), and sex determination testing
- Healthcare insurance (Convênios): Partnership with health insurance providers for covered diagnostic services
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Citolab product offering
Product offeringCore offering
Citolab is a clinical cytology and histopathology laboratory providing anatomical pathology, biopsy and surgical specimen analysis, cytology (conventional and liquid-based SurePath), automated immunohistochemistry with 48-72 hour turnaround, molecular diagnostics including NGS hereditary cancer panels, HPV genotyping, and specialized pathology services. The lab also offers genetic testing (nutrigenetics, sports genetics, dermatogenetics), prenatal testing (NIPT, fetal sexing), infectious disease panels, and COVID-19 antigen testing for healthcare providers and patients in the Curitiba metropolitan region.
Product overview
Citolab is a clinical cytology and histopathology laboratory offering comprehensive anatomical pathology and diagnostic testing services. The core portfolio centers on anatomical pathology services including surgical specimen analysis, biopsies, cytology (conventional and liquid-based), and intraoperative frozen section examinations. The laboratory provides specialized immunohistochemistry with automated 48-72 hour turnaround and molecular diagnostics including NGS hereditary cancer panels (26 genes), HPV genotyping, and KRAS/NRAS/BRAF testing. Citolab also offers genetic testing services (NutriGen, GymGen, FitGen, AgeGen) for nutrigenetics, athletic performance, fitness optimization, and dermatogenetics. Prenatal testing includes NIPT and fetal sexing via PCR. The service portfolio spans oncology diagnostics, infectious disease testing (STI panels, COVID-19), neuropathology, dermatopathology, and mastopathology, complemented by 24-hour logistics support and digital result delivery. The laboratory operates multiple collection sites in Curitiba and São José dos Pinhais with priority service for transplant patients.
Differentiator
Problem solved
Functional benefit
Products and services
- Anatomical Pathology / Biopsies / Surgical Specimens
- Cytopathology (Liquid-Based and Conventional)
- Immunohistochemistry / Immunocytochemistry
- Molecular Diagnostics (NGS Hereditary Cancer Panel)
- HPV Testing and Genotyping
- NIPT - Non-Invasive Prenatal Test
- Neuropathology Services
- Dermatopathology Services
- Mastopathology Services
- NutriGen - Nutrigenetic Test
- GymGen / FitGen - Genetic Sports and Fitness Tests
- AgeGen - Dermatogenetic Test
- STI/IST Molecular Panel
- KRAS/NRAS/BRAF Molecular Studies
- Microsatellite Instability (MSI) Testing
- COVID-19 Antigen Rapid Test
- Per-Operative Frozen Section Examination
- Fine Needle Aspiration Biopsy (FNAB)
- Second Opinion / Slide Review
- 24-Hour Logistics Assistance
Quantifiable outcome
- Immunohistochemistry turnaround time of 48-72 hours
- +3 more outcomes
Companies that use Citolab
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Citolab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Citolab partnerships and signals
Strategic signalScale indicators4 records
Recent moves8 records
Expansion highlights3 records
Citolab competitors and assessment
Company assessmentOthers
- Genomic Health (Exact Sciences): US-based molecular diagnostics company commercialising Oncotype DX and other genomic oncology tests globally. Not a direct competitor but provides comparable molecular/genomic oncology testing that Brazilian specialty labs like Citolab compete against in hereditary cancer and tumor profiling cases.
- Hospital Israelita Albert Einstein: Brazilian tertiary hospital system operating an integrated clinical laboratory and reference diagnostic service for complex and esoteric testing. Adjacent rather than directly competing with Citolab, but engages the same specialist pathologists and serves overlapping subspecialty referral cases from across Brazil.
Direct peers
- Sabin Medicina Diagnóstica: Brazilian diagnostic medicine chain offering clinical analysis, imaging, and specialty testing through a network of patient service centers across multiple states. Closest direct comparable in business model to Citolab: anatomical pathology, molecular diagnostics, convênio partnerships, and physician-referred testing in a Brazilian regional hub context.
- Laboratório Hermes Pardini: Large Brazilian clinical laboratory with a strong specialty and molecular diagnostics portfolio, including genetic testing and hospital partnerships. Highly comparable to Citolab in test menu breadth (oncology IHC, molecular, genetics) and target customer base (hospitals, clinicians, convênios), though at materially larger national scale.
- DB Diagnósticos: Brazilian clinical diagnostics chain with regional presence focused on routine and specialty testing for physicians, hospitals, and convênios. Comparable to Citolab in business model (clinical analysis, convênio billing, physician referrals) and regional hub footprint in Brazil.
Broad incumbents
- Quest Diagnostics: US clinical laboratory incumbent offering anatomical pathology, molecular diagnostics, and genetic testing at nationwide scale through physician and hospital channels. Comparable to Citolab in test categories and physician-referred anatomical pathology, but vastly larger and operating in a different regulatory and reimbursement environment.
- Dasa (Diagnósticos da América): Largest Brazilian integrated diagnostics company operating brands such as Delboni Auriemo, Sérgio Franco, and Pasteur across clinical analysis, imaging, and hospital diagnostics. Operates in the same anatomical pathology, molecular, and convênio-driven market as Citolab but at national scale across hundreds of units and integrated hospital systems.
- NeoGenomics: US specialty oncology testing company focused on molecular and anatomic pathology for hospitals, oncologists, and clinical trials. Highly comparable to Citolab in subspecialty oncology and molecular focus, though operating at multi-state US scale rather than regional Brazilian scale.
- Fleury: Major Brazilian diagnostics company offering clinical analysis, imaging, and specialty testing with a strong reference-lab positioning in oncology and genetics. Comparable to Citolab in subspecialty test offerings and physician-referral channel, but with a São Paulo-centric premium positioning and far larger operating scale.
Emerging players
- Natera: US-based cell-free DNA testing company with leading NIPT, hereditary cancer, and oncology monitoring products. Direct comparable to Citolab's NIPT and hereditary cancer NGS panel offerings, though Natera operates globally as a specialty molecular company rather than a regional full-service pathology lab.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Citolab social profiles
Digital presenceCitolab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Citolab leadership team
Management profileNumber of profiles
Profiles6 records
Citolab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Citolab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Citolab
What does Citolab do?
Citolab is a clinical cytology and histopathology laboratory providing anatomical pathology, biopsy and surgical specimen analysis, cytology (conventional and liquid-based SurePath), automated immunohistochemistry with 48-72 hour turnaround, molecular diagnostics including NGS hereditary cancer panels, HPV genotyping, and specialized pathology services. The lab also offers genetic testing (nutrigenetics, sports genetics, dermatogenetics), prenatal testing (NIPT, fetal sexing), infectious disease panels, and COVID-19 antigen testing for healthcare providers and patients in the Curitiba metropolitan region.
Is Citolab a public or private company?
Citolab is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Citolab founded?
Citolab was founded in 1989. It employs 11 to 50 people.
Where is Citolab based?
Citolab is headquartered in Curitiba, Brazil, in the Latin America region.
How does Citolab make money?
Three revenue lines are on record. Clinical pathology services are the primary driver. The others are specialized diagnostic testing and healthcare insurance (Convênios).
Who are Citolab's main competitors?
Others on record are Genomic Health (Exact Sciences) and Hospital Israelita Albert Einstein. Direct peers are Sabin Medicina Diagnóstica, Laboratório Hermes Pardini and DB Diagnósticos. Broad incumbents are Quest Diagnostics, Dasa (Diagnósticos da América), NeoGenomics and Fleury. Natera is listed as an emerging player.
Does Citolab have an API?
No public API is recorded for Citolab.
What industry is Citolab in?
Citolab's product category is Clinical Pathology Laboratory Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.